Multiple Myeloma
Clinical Trials

1)Relapsed/Refractory MM/ IONA: A prospective, non-interventional, multinational, observational study with Isatuximab in patients with relapsed and/or refractory multiple myeloma (RRMM)

Send UsA Message

    Game Changing Neoadjuvant Lung Trial Enrolls the Most People in the World

    Game Changing Neoadjuvant Lung Trial Enrolls the Most People in the World

    Charleston Oncology’s Clinical Trials most recent non–small cell lung cancer trial enrolled the most people in the world. Gene Saylors, MD, oncologist and hematologist at Charleston Oncology, will present the positive findings at the American Association for Cancer Research 2022 Annual Meeting. “When administering a new trial, we are always cautiously optimistic,” says Dr. Gene Saylors. “The positive results of this Neoadjuvant Lung Trial resulted in rapid FDA approval due to its impressive outcomes.”

    read more
    Sarcoma and Bone Cancer Awareness

    Sarcoma and Bone Cancer Awareness

    July is Sarcoma and Bone Cancer Awareness Month. Sarcomas are a rare group of cancers in which malignant cells form in the bones or soft tissues of the body.

    read more
    May is Skin Cancer Awareness Month

    May is Skin Cancer Awareness Month

    Melanoma is a type of skin cancer that develops when melanocytes start to grow out of control. Watch a video to learn more about melanoma from Dr. Charles S. Holladay.

    read more
    Call Now Button